Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Paya Carlos V, Director. Insider active across 5 companies, notably Fluidigm CORP. In total, 11 filings have been logged. Activity tracked since 25 May 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
11 of 11 declarations
Carlos V. Paya is a Board Member at FLUIDIGM CORP, Vaxcyte, Inc., and STANDARD BIOTOOLS INC. He brings expertise in biotechnology and product development. His role involves overseeing operations and guiding the strategy of these companies, which are at the forefront of innovation in the healthcare sector.